Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease

Food and Chemical Toxicology

Volumn 48, Issue 3, 2010, Pages 798-802

  Chonpathompikunlert, Pennapa ^a   Wattanathorn, Jintanaporn ^b   Muchimapura, Supaporn ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Neuroprotective; Neurotrophic effect; Piperine; Spatial memory

Indexed keywords

ACETYLCHOLINESTERASE; DONEPEZIL; ETHYLCHOLINE MUSTARD AZIRIDINIUM; PIPERINE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLACK PEPPER; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG SCREENING; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; NERVE DEGENERATION; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; RAT; SPATIAL MEMORY;

ACETYLCHOLINESTERASE; ALKALOIDS; ALZHEIMER DISEASE; ANIMALS; AZIRIDINES; BENZODIOXOLES; BLACK PEPPER; CHOLINE; COGNITION DISORDERS; HIPPOCAMPUS; INDANS; INJECTIONS, INTRAVENTRICULAR; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MAZE LEARNING; NERVE DEGENERATION; NEUROMUSCULAR BLOCKING AGENTS; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RATS; SPACE PERCEPTION; THAILAND;

ANIMALIA; PIPER NIGRUM; RATTUS NORVEGICUS;

EID: 76749159471     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.12.009     Document Type: Article

References (33)

1. Andres-Lacueva C., Shukitt-Hale B., Galli R.L., Jauregui O., Lamuela-Raventos R.M., and Joseph J.A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr. Neurosci. 8 2 (2005) 111-120
2. Bai Y.F., and Xu H. Protective action of piperine against experimental gastric ulcer. Acta Pharmacol. Sin. 21 (2000) 357-359
3. Calabrese V., Butterfield D.A., and Stella A.M. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. Ital. J. Biochem. 52 4 (2003) 177-181
4. Coyle J.T., Price D.L., and DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219 (1983) 1184-1190
5. Devi L., Diwakar L., Raju T.R., and Kutty B.M. Selective neurodegeneration of hippocampus and entorhinal cortex correlates with spatial learning impairments in rats with bilateral ibotenate lesions of ventral subiculum. Brain Res. 960 1-2 (2003) 9-15
6. D'Hooge R., Pei Y.Q., Raes A., Lebrun P., Van Bogaert P.P., and De Deyn P.P. Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists. Arzneimittelforschung 46 (1996) 557-560
7. Emilien G., Beyreuther K., Masters C.L., and Maloteaux J.M. Prospects for pharmacological intervention in Alzheimer disease. Arch. Neurol. 57 4 (2000) 454-459
8. Filley C.M. Alzheimer's disease: it's irreversible but not untreatable. Geriatrics 50 7 (1995) 18-23
9. Francis P.T., Palmer A.M., Snape M., and Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 66 2 (1999) 137-147
10. Galli R.L., Shukitt-Hale B., Youdim K.A., and Joseph J.A. Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann. N. Y. Acad. Sci. 959 (2002) 128-132
11. Ghelardini C., Galeotti N., Barboloni A., and Furukawa S. Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the acetylcholine releaser PG-9. Jpn. J. Pharmacol. 78 (1998) 245-251
12. Gupta S.K., Bansal P., Bhardwaj R.K., and Velpandian T. Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharmacol. Res. 41 (2000) 657-662
13. Hanin I. The AF64A model of cholinergic hypofunction: an update. Life Sci. 58 22 (1996) 1955-1964
14. Harman D. Aging and oxidative stress. JIFFC 10 l (1998) 24-27
15. Jabeen B., Badaruddin M., Ali R., and Haleem D.J. Attenuation of restraint-induced behavioral deficits and serotonergic responses by stabilized rice bran in rats. Nutr. Neurosci. 10 1-2 (2007) 11-16
16. Kong L.D., Cheng C.H.K., and Tan R.X. Inhibition of MAO A and B by some plant derived alkaloids, phenols and anthraquinones. J. Etnopharmacol. 2-3 (2004) 351-355
17. Kontush K., and Schekatolina S. Vitamin E in neurodegenerative disorders: Alzheimer's disease. Ann. N. Y. Acad. Sci. 1031 (2004) 249-262
18. Lee S.A., Hong S.S., Han X.H., Hwang J.S., Oh G.J., Lee K.S., Lee M.K., Hwang B.Y., and Ro J.S. Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity. Chem. Pharm. Bull. 53 (2005) 832-835
19. Liston D.R., Nielsen J.A., Villalobos A., Chapin D., Jones S.B., Hubbard S.T., Shalaby I.A., Ramirez A., Nason D., and White W.F. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. Eur. J. Pharmacol. 486 1 (2004) 9-17
20. Lyras L., Cairns N.J., Jenner A., Jenner P., and Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68 (1997) 2061-2069
21. Mecocci P., Cherubini A., Polidori M.C., Cecchetti R., Chionne F., and Senin U. Oxidative stress and dementia: new perspectives in AD pathogenesis. Aging (Milano) 9 4 Suppl. (1997) 51-52
22. Oswald C.J., and Good D. The effect of combined lesion of subicular complex and entorhinal cortex on two forms of spatial navigation in the water maze. Behav. Neurosci. 114 1 (2000) 211-217
23. Parle M., Dhingra D., and Kulkarni S.K. Neurochemical basis of learning and memory. Indian J. Pharm. Sci. 66 (2004) 371-376
24. Peng W.H., Hisch M.T., and Wu C.R. Effect of long term administration of berberine of scopolamine induced amnesia in rats. Jpn. J. Pharmacol. 74 (1997) 261-265
25. Perry E., Walker M., Grace J., and Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness?. TINS 22 (1999) 273-280
26. Qizilbash N., Birks J., Lopez Arrieta J., Lewington S., and Szeto S. Cochrane Database Syst. Rev. 1 3 (2007) CD000202
27. Raghavendra V., and Kulkarni S.K. Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. Free Radic. Biol. Med. 30 6 (2001) 595-602
28. Selvendiran K., Singh J.P., Krishnan K.B., and Sakthisekaran D. Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia 74 (2003) 109-115
29. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., and Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease. Proc. Natl. Acad. Sci. USA 88 (1991) 10540-10543
30. Wattanathorn J., Chonpathompikunlert P., Muchimapura S., Priprem A., and Tankamnerdthai O. Piperine, the potential functional food for mood and cognitive disorders. Food Chem. Toxicol. 46 9 (2008) 3106-3110
31. Wenk G.L., Stoehr J.D., Mobley S.L., Gurney J., and Morris R.J. Age-related decrease in vulnerability to excitatory amino acids in the nucleus basalis. Neurobiol. Aging 17 1 (1996) 1-7
32. Youdim K.A., Spencer J.P., Schroeter H., and Rice-Evans C. Dietary flavonoids as potential neuroprotectants. Biol. Chem. 383 3-4 (2002) 503-519
33. Zarotsky V., Sramek J.J., and Cutler N.R. Galantamine hydrobromide: an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60 5 (2003) 446-452